Abstract:
A novel poly(caprolactone-methyl methacrylate) copolymer, a method for preparing the copolymer, and a method for preparing an agent for treating the skin disease such as acne, atopy, athlete's foot, etc. by using the copolymer are provided to control the drug delivery velocity and to improve skin disease treatment efficiency by increasing effective crosssectional area. A poly(caprolactone-methyl methacrylate) copolymer comprises the repeating unit represented by the formula and has a number average molecular weight of 5,000-50,000, wherein m and n are 10-1,000, respectively. The copolymer is prepared by injecting caprolactone and methyl methacrylate into a reactor in a ratio of 1:1 TO 1:1.5 by weight; injecting a 2,2-azobisisobutyronitrile initiator in a ratio of 0.1-1.0 by weight to the total amount of the monomers; and polymerizing them at a temperature of 283.15-353.15 K and at a pressure of 50-300 atm for 1-168 hours.
Abstract:
A method for preparing salicylic acid microparticles is provided to obtain fine salicylic acid particles having an increased effective surface area and showing increasing skin absorptivity. A method for preparing salicylic acid microparticles utilizes a supercritical fluid process in which a mixed solution containing salicylic acid dissolved in an organic solvent is sprayed to and contacted with a supercritical fluid to produce salicylic acid particles, and then a supercritical fluid is introduced thereto to remove the organic solvent. In the method, the organic solvent is used in an amount corresponding to a weight fraction of salicylic acid of 0.0001-0.50.
Abstract:
A process for producing nanoparticles of imidazole is provided to increase the effective sectional area of imidazole particles and skin absorption rate of imidazole through the supercritical fluid process using supercritical carbon dioxide, so that the therapeutic effects of imidazole on dandruff are improved. A process for producing nanoparticles of imidazole comprises the steps of: (1) dissolving 0.0001-0.50 wt.% of imidazole in ethanol as an organic solvent to prepare a mixture solution; (2) contacting the mixture solution with supercritical carbon dioxide as supercritical fluid through spraying to form imidazole nanoparticles; (3) removing the organic solvent from the imidazole nanoparticles by using the additional supercritical fluid; and (4) recovering the formed imidazole nanoparticles.
Abstract:
A process for producing nanoparticles of panthenol is provided to increase skin absorption rate of panthenol by increasing effective cross section through supercritical fluid process, so that the nanoparticles of panthenol are useful for treating acnes without side effects. A process for producing nanoparticles of panthenol comprises the steps of: solubilizing 0.0001-0.50 wt.% of panthenol in organic solvent such as ethanol to prepare the panthenol solution; spraying the panthenol solution to supercritical fluid to form panthenol nanoparticles; and removing the organic solvent from the panthenol nanoparticles by introducing the additional supercritical fluid to the panthenol nanoparticles; and collecting the formed panthenol nanoparticles.
Abstract:
A method for preparing nano-particles of piroctone olamine is provided to micronize the piroctone olamine through a supercritical fluid process using a supercritical CO2, thereby obtaining the piroctone olamine with increased skin absorption rate due to increased effective cross section. A method for preparing nano-particles of piroctone olamine comprises the steps of: (a) contacting a mixture solvent obtained by dissolving piroctone olamine into an organic solvent with a supercritical fluid by spraying the mixture solvent to generate piroctone olamine particles; and (b) removing the organic solvent from the particles by introducing a supercritical fluid thereinto, wherein 0.0001-0.50 wt.%, preferably 0.001-0.20 wt.% of the organic solvent is used regarding the weight of the piroctone olamine.
Abstract:
A method for preparing a ceramide nano-particle is provided to obtain the ceramide with increased skin absorption rate due to increase of an effective cross-sectional area by micronizing a particle size of the ceramide through a supercritical fluid process using a supercritical CO2. A method for preparing a ceramide nano-particle comprises the steps of: (a) mixing 0.0001-0.50 wt.% of ceramide with ethanol to prepare a mixture solution; (b) spraying the mixture solution with the speed of 0.5-1.5ml/minute into a reactor where CO2 is contained at a temperature of 313-333K under a pressure of 130-170 bar with injecting CO2 into the reactor with the speed of 2.5-3.5kg/hour to generate ceramide particles; and (c) introducing CO2 into the reactor to remove the ethanol therefrom to prepare ceramide particles having a size of 50-150 nanometers.
Abstract:
A method for preparing a nanostructure containing vitamin K is provided to solve a problem of remaining organic solvent by using a supercritical fluid extraction system and increase the skin permeation rate of the vitamin K by nano-sizing the vitamin K and control the medicinal effect delivering speed of a drug by containing a biodegradable polymer together with the drug. A method for preparing a nanostructure comprises the steps of: (a) dissolving vitamin K and a biodegradable polymer such as poly-isopropyl-butylmethacrylate-acrylic acid copolymer in an organic solvent such as ethanol to prepare a mixture solution; (b) spraying the mixture solution into a reactor containing a supercritical fluid such as CO2 to generate spherical vitamin K structure particles; (c) further introducing the supercritical fluid same as the step(b) into the reactor containing the spherical vitamin K structure particles to remove the organic solvent therefrom; and (d) recovering the organic solvent removed vitamin K structure particles.
Abstract:
A process for preparing ascorbic acid nanoparticles is provided to increase skin absorption rate of ascorbic acid by increasing the sectional area of ascorbic acid particles and improve skin striae-treating effects of ascorbic acid by using rapid expansion of supercritical system. A process for preparing ascorbic acid nanoparticles comprises the steps of: dissolving 0.0001-0.50 wt.% based on the weight of ethanol of ascorbic acid in ethanol; spraying the ascorbic acid dissolved solvent to the supercritical carbon dioxide through a nozzle to prepare ascorbic acid nanoparticles; flowing the supercritical carbon dioxide to the ascorbic acid nanoparticles in several times to extract and remove ethanol; and recovering the ascorbic acid nanoparticles.
Abstract:
A process for preparing phytoestrogen nanoparticles is provided to improve acne-treating effects of phytoestrogen by increasing skin absorption rate and sectional area of phytoestrogen particles through the supercritical fluid process. The phytoestrogen nanoparticles are prepared by dissolving phytoestrogen in organic solvent selected from methanol and ethanol to prepare a mixture solution, contacting the mixture solution with the supercritical fluid selected from supercritical carbon dioxide, supercritical nitrogen monoxide, supercritical methane trichloride, supercritical propane, supercritical ethylene and supercritical xenon through spraying to form phytoestrogen nanoparticles, washing the phytoestrogen nanoparticles by introducing the additional supercritical fluid into the phytoestrogen nanoparticles, and recovering the phytoestrogen nanoparticles having the particle size of 100-300 nm.
Abstract:
A method for preparing nano-triclocarban is provided to obtain ultra-fine particles of triclocarban with predicted skin efficacy due to increased effective cross-section, thereby the nano-triclocarban being applied to quasi-drugs. A method for preparing nano-triclocarban comprises the steps of: (a) dissolving triclocarban into an organic solvent; (b) spraying the mixture solution obtained from the step(a) into a supercritical fluid to generate triclocarban particles; (c) introducing a supercritical fluid into the particles to remove the organic solvent therefrom; and (d) recovering the generated particles, wherein the organic solvent used regarding the organic solvent is 0.0001-0.50 wt.%, preferably 0.001-0.20 wt.%.